Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Thursday's Intraday Session

 

Gainers

  • Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus Holdings's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $2.6 billion. As per the press release, Q4 earnings came out today.
  • TransMedics Group (NASDAQ:TMDX) shares rose 23.68% to $15.56. As of 12:30 EST, this security is trading at a volume of 375.1K shares, making up 211.8% of its average full-day volume over the last 100 days. The company's market cap stands at $432.0 million. The company's, Q4 earnings came out yesterday.
  • Liquidia (NASDAQ:LQDA) stock rose 17.27% to $6.11. As of 12:30 EST, Liquidia's stock is trading at a volume of 636.3K, which is 133.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $317.5 million.
  • Evolent Health (NYSE:EVH) stock increased by 16.11% to $25.79. As of 12:30 EST, Evolent Health's stock is trading at a volume of 1.6 million, which is 316.0% of its average full-day volume over the last 100 days. The company's market cap stands at $2.3 billion. As per the news, the Q4 earnings report came out yesterday.
  • Vericel (NASDAQ:VCEL) shares increased by 15.66% to $37.22. Trading volume for this security as of 12:30 EST is 469.8K, which is 90.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.7 billion. As per the news, the Q4 earnings report came out today.
  • Clover Health Investments (NASDAQ:CLOV) stock rose 14.42% to $2.3. Clover Health Investments's stock is trading at a volume of 28.9 million shares as of 12:30 EST. This is 201.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion. As per the news, the Q4 earnings report came out yesterday.

 

Losers

  • Orphazyme (NASDAQ:ORPH) shares decreased by 33.7% to $1.34 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 2.1 million, which is 224.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $47.3 million.
  • Tabula Rasa HealthCare (NASDAQ:TRHC) stock decreased by 27.76% to $4.38. As of 12:30 EST, this security is trading at a volume of 1.4 million shares, making up 254.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $112.7 million. As per the news, the Q4 earnings report came out today.
  • MannKind (NASDAQ:MNKD) shares decreased by 23.37% to $2.81. As of 12:30 EST, this security is trading at a volume of 7.4 million shares, making up 287.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $704.7 million. As per the news, the Q4 earnings report came out today.
  • Revelation Biosciences (NASDAQ:REVB) shares declined by 17.99% to $1.71. The current volume of 1.3 million shares is 85.4% of Revelation Biosciences's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $24.2 million.
  • Provention Bio (NASDAQ:PRVB) stock fell 16.54% to $5.35. Provention Bio's stock is trading at a volume of 903.7K shares as of 12:30 EST. This is 89.1% of its average full-day volume over the last 100 days. The company's market cap stands at $339.0 million. As per the press release, Q4 earnings came out today.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) stock declined by 15.21% to $0.98. Trading volume for TC BioPharm (Holdings)'s stock is 434.2K as of 12:30 EST. This is 13.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $27.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.